Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 11/20 | 0.47 |
| ▸ | TNK2 | Q07912 | 2/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | JAK3 | P52333 | 1/20 | 0.45 |
| ▸ | BTK | Q06187 | 1/20 | 0.45 |
| ▸ | HCK | P08631 | 1/20 | 0.42 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.42 |
| ▸ | TTK | P33981 | 1/20 | 0.42 |
| ▸ | SIK1 | P57059 | 2/20 | 0.41 |
| ▸ | SIK2 | Q9H0K1 | 2/20 | 0.41 |
| ▸ | SIK3 | Q9Y2K2 | 2/20 | 0.41 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | AXL | P30530 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30962930 | 0.93 | SRC (0.46) | SRCTNK2LCKJAK3HCK | |
| SCHEMBL30962929 | 0.93 | SRC (0.46) | SRCTNK2LCKJAK3HCK | |
| SCHEMBL30962853 | 0.91 | TNK2 (0.48) | SRCTNK2LCKJAK3BTK | |
| SCHEMBL30962666 | 0.90 | JAK3 (0.42) | SRCTNK2LCKJAK3BTK | |
| SCHEMBL30962748 | 0.90 | SRC (0.44) | SRCLCKJAK3HCKFGFR1 | |
| SCHEMBL30962895 | 0.90 | SRC (0.44) | SRCLCKJAK3HCKFGFR1 | |
| SCHEMBL30962835 | 0.89 | JAK3 (0.41) | SRCTNK2LCKJAK3BTK | |
| SCHEMBL30962900 | 0.89 | TTK (0.43) | SRCTNK2LCKJAK3BTK | |
| SCHEMBL30962759 | 0.84 | SRC (0.47) | SRCLCKJAK3HCKFGFR1 | |
| SCHEMBL30962907 | 0.84 | SRC (0.47) | SRCLCKJAK3HCKFGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642767-A1 | PYRIMIDINE CARBOXAMIDE COMPOUNDS | Acrivon Therapeutics, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |